Overview Financials News + Filings Key Docs Charts Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Quarterly results
|
Aligos Therapeutics, Inc. (ALGS)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
07/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/17/2023 |
4
| McClure Matthew W. (Chief Medical Officer) has filed a Form 4 on Aligos Therapeutics, Inc.
Txns:
| Granted 75,000 options to buy
@ $1.34, valued at
$100.5k
|
|
03/17/2023 |
4
| Symons Julian A. (See Remarks) has filed a Form 4 on Aligos Therapeutics, Inc.
Txns:
| Granted 78,750 options to buy
@ $1.34, valued at
$105.5k
|
|
03/17/2023 |
4
| Calhoun Lesley Ann (See Remarks) has filed a Form 4 on Aligos Therapeutics, Inc.
Txns:
| Granted 78,750 options to buy
@ $1.34, valued at
$105.5k
|
|
03/17/2023 |
4
| Quan Lucinda Y. (See Remarks) has filed a Form 4 on Aligos Therapeutics, Inc.
Txns:
| Granted 78,750 options to buy
@ $1.34, valued at
$105.5k
|
|
03/17/2023 |
4
| Beigelman Leonid (President) has filed a Form 4 on Aligos Therapeutics, Inc.
Txns:
| Granted 169,500 options to buy
@ $1.34, valued at
$227.1k
|
|
03/17/2023 |
4
| BLATT LAWRENCE (CEO) has filed a Form 4 on Aligos Therapeutics, Inc.
Txns:
| Granted 242,500 options to buy
@ $1.34, valued at
$325k
|
|
07/11/2022 |
4
| McClure Matthew W. (Chief Medical Officer) has filed a Form 4 on Aligos Therapeutics, Inc.
Txns:
| Granted 46,000 options to buy
@ $1.41, valued at
$64.9k
|
|
07/11/2022 |
4
| Quan Lucinda Y. (See Remarks) has filed a Form 4 on Aligos Therapeutics, Inc.
Txns:
| Granted 52,500 options to buy
@ $1.41, valued at
$74k
|
|
07/11/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/11/2022 |
4
| Beigelman Leonid (President) has filed a Form 4 on Aligos Therapeutics, Inc.
Txns:
| Granted 113,000 options to buy
@ $1.41, valued at
$159.3k
|
|
07/11/2022 |
4
| BLATT LAWRENCE (CEO) has filed a Form 4 on Aligos Therapeutics, Inc.
Txns:
| Granted 161,700 options to buy
@ $1.41, valued at
$228k
|
|
07/11/2022 |
4
| Symons Julian A. (See Remarks) has filed a Form 4 on Aligos Therapeutics, Inc.
Txns:
| Granted 50,000 options to buy
@ $1.41, valued at
$70.5k
|
|
06/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/08/2022 |
4
| Symons Julian A. (See Remarks) has filed a Form 4 on Aligos Therapeutics, Inc.
Txns:
| Granted 105,000 options to buy
@ $3.06, valued at
$321.3k
Granted 26,250 options to buy
@ $3.06, valued at
$80.3k
|
|
02/08/2022 |
4
| BLATT LAWRENCE (CEO) has filed a Form 4 on Aligos Therapeutics, Inc.
Txns:
| Granted 323,400 options to buy
@ $3.06, valued at
$989.6k
Granted 80,850 options to buy
@ $3.06, valued at
$247.4k
|
|
02/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/08/2022 |
4
| Quan Lucinda Y. (See Remarks) has filed a Form 4 on Aligos Therapeutics, Inc.
Txns:
| Granted 105,000 options to buy
@ $3.06, valued at
$321.3k
Granted 26,250 options to buy
@ $3.06, valued at
$80.3k
|
|
02/08/2022 |
4
| Beigelman Leonid (President) has filed a Form 4 on Aligos Therapeutics, Inc.
Txns:
| Granted 226,800 options to buy
@ $3.06, valued at
$694k
Granted 56,700 options to buy
@ $3.06, valued at
$173.5k
|
|
11/18/2021 |
4
| Martell Bridget A (Director) has filed a Form 4 on Aligos Therapeutics, Inc.
Txns:
| Granted 30,000 options to buy
@ $16.52, valued at
$495.6k
|
|
06/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
06/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|
|
|